Tag: Kymriah
Post NHS approval, sky is the limit for Novartis’ CAR-T therapy:...
According to GlobalData forecasts, the Novartis CAR-T therapy, Kymriah is expected to hit over $1billion sales revenue by 2023 in the US alone......……….